Publicaciones (36) Publicaciones en las que ha participado algún/a investigador/a

2019

  1. 30º Congreso de la Sociedad Española de Transfusión Sanguínea y Terapia Celular (SETS), Madrid (España), 6-8 Junio 2019

    Blood transfusion = Trasfusione del sangue, Vol. 17, Núm. 17, pp. s201-s406

  2. A Three-Gene Expression Signature Identifies a Cluster of Patients with Short Survival in Chronic Lymphocytic Leukemia

    Journal of Oncology, Vol. 2019

  3. ABO incompatible live donor renal transplant. Study of 48 patients after desensitization

    Nefrologia, Vol. 39, Núm. 6, pp. 612-622

  4. An analysis of the impact of CD56 expression in de novo acute promyelocytic leukemia patients treated with upfront all-trans retinoic acid and anthracycline-based regimens

    Leukemia and Lymphoma, Vol. 60, Núm. 4, pp. 1030-1035

  5. Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure without the need for immunotherapy

    Hematology/ Oncology and Stem Cell Therapy, Vol. 12, Núm. 4, pp. 194-203

  6. Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group

    British Journal of Haematology, Vol. 184, Núm. 5, pp. 797-807

  7. Clinical significance of complex karyotype at diagnosis in pediatric and adult patients with de novo acute promyelocytic leukemia treated with ATRA and chemotherapy

    Leukemia and Lymphoma, Vol. 60, Núm. 5, pp. 1146-1155

  8. Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia

    Scientific Reports, Vol. 9, Núm. 1

  9. El valor de la palabra entre el médico y el paciente

    Práctica Familiar Rural, Vol. 4, Núm. 3

  10. Identification of 58 mutations (26 Novel) in 94 of 109 symptomatic Spanish probands with protein C deficiency

    Thrombosis and Haemostasis, Vol. 119, Núm. 9, pp. 1409-1418

  11. In vitro evaluation of pathogen inactivated platelet quality: An 8 year experience of routine use in Galicia, Spain

    Transfusion and Apheresis Science, Vol. 58, Núm. 1, pp. 87-93

  12. Involvement of antifactor VIII autoantibodies specificity in the outcome of inhibitor eradication therapies in acquired hemophilia a patients

    Blood Coagulation and Fibrinolysis, Vol. 30, Núm. 3, pp. 127-132

  13. Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study

    The Lancet, Vol. 394, Núm. 10214, pp. 2096-2107

  14. Joint status in Spanish haemophilia B patients assessed using the Haemophilia Early Arthropathy Detection with Ultrasound (HEAD-US) score

    Haemophilia, Vol. 25, Núm. 1, pp. 144-153

  15. LINFOMA DE HODGKIN: CUANDO PIENSAS QUE TODO VA BIEN. NUESTRA EXPERIENCIA EN VIDA REAL

    HAEMATOLOGICA, Vol. 104, Núm. Supl. 3, pp. 388-389

  16. Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population

    British Journal of Haematology, Vol. 185, Núm. 3, pp. 480-491

  17. MEASURABLE RESIDUAL DISEASE IN APHERESIS BAGS INTENDED FOR TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA

    HAEMATOLOGICA, Vol. 104, Núm. Supplement 3, pp. 251

  18. Management of adult patients with primary immune thrombocytopenia (itp) in clinical practice: A consensus approach of the Spanish itp expert group

    Advances in Hematology, Vol. 2019

  19. New Recurrent Structural Aberrations in the Genome of Chronic Lymphocytic Leukemia Based on Exome-Sequencing Data

    Frontiers in Genetics, Vol. 10

  20. ORAL VP16 IN THE AMBULATORY MANAGEMENT OF PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA

    HAEMATOLOGICA, Vol. 104, Núm. Supplement 3, pp. 439